Suchergebnisse - "Capparelli, Edmund V"

PubPharm (283)

1

Acceptability and tolerability of long-acting injectable cabotegravir or rilpivirine in the first cohort of virologically suppressed adolescents living with HIV (IMPAACT 2017/MOCHA) : a secondary analysis of a phase 1/2, multicentre, open-label, non-comparative dose-finding study

enthalten in: The lancet. HIV | 2024

von Lowenthal, E. | Chapman, J. | Ohrenschall, R. | +36

2

Safety and pharmacokinetics of oral and long-acting injectable cabotegravir or long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA) : a phase 1/2, multicentre, open-label, non-comparative, dose-finding study

enthalten in: The lancet. HIV | 2024

von Gaur, A. | Capparelli, E. | Calabrese, K. | +40

3

Phase 1 trial evaluating safety and pharmacokinetics of HIV-1 broadly neutralizing mAbs 10E8VLS and VRC07-523LS

enthalten in: JCI insight | 2024

von Awan, S. | Pegu, A. | Strom, L. | +34

4

Safety and Pharmacokinetics of Lopinavir/Ritonavir Oral Solution in Preterm and Term Infants Starting Before 3 Months of Age

enthalten in: The Pediatric infectious disease journal | 2024

von Bekker, A. | Yang, J. | Wang, J. | +11

5

HIV-1 reservoir size after neonatal antiretroviral therapy and the potential to evaluate antiretroviral-therapy-free remission (IMPAACT P1115) : a phase 1/2 proof-of-concept study

enthalten in: The lancet. HIV | 2024

von Persaud, D. | Bryson, Y. | Nelson, B. | +19

6

Paediatric abacavir-lamivudine fixed-dose dispersible tablets and ritonavir-boosted lopinavir granules in neonates exposed to HIV (PETITE study) : an open-label, two-stage, single-arm, phase 1/2, pharmacokinetic and safety trial

enthalten in: The lancet. HIV | 2024

von Bekker, A. | Salvadori, N. | Rabie, H. | +10

ErratumIn: Lancet HIV. 2024 Apr 5;:. - PMID 38588690

7

Brief Report : Dolutegravir Plasma Protein Binding and Unbound Concentrations During Pregnancy and Postpartum

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2023

von Momper, J. | Nikanjam, M. | Best, B. | +3

8

Pharmacokinetics and safety of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum : results from IMPAACT P1026s

enthalten in: Antimicrobial agents and chemotherapy | 2023

von Van Schalkwyk, M. | Bekker, A. | Decloedt, E. | +18

9

Variable Delta-9-Tetrahydrocannabinol Pharmacokinetics and Pharmacodynamics After Cannabis Smoking in Regular Users

enthalten in: Therapeutic drug monitoring | 2023

von Liyanage, M. | Nikanjam, M. | Capparelli, E. | +5

10

Model-Informed Precision Dosing Guidance of Ethosuximide Developed from a Randomized Controlled Clinical Trial of Childhood Absence Epilepsy

enthalten in: Clinical pharmacology and therapeutics | 2023

von Mizuno, K. | Capparelli, E. | Fukuda, T. | +10

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[29]